| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 02/27/2008 | EP1740530A4 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders |
| 02/27/2008 | EP1237872B1 Compounds and compositions for delivering active agents |
| 02/27/2008 | CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 02/27/2008 | CN100370975C Inhibitors against the production and releaseof inflammator cytokines |
| 02/26/2008 | US7335751 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
| 02/21/2008 | US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 02/21/2008 | US20080045483 such as 4-{2-[2-(4-chlorobenzenesulfonylamino)phenyl]ethyl}benzoic acid; hyperglycemic agents |
| 02/20/2008 | EP1888566A1 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 02/20/2008 | EP1888564A2 Benzofuran compounds |
| 02/20/2008 | EP1888508A2 Novel haloalkoxy-substituted salicylic anilides |
| 02/20/2008 | EP1888505A1 Organic compounds |
| 02/20/2008 | EP1697304B1 Peroxisome proliferator activated receptor modulators |
| 02/20/2008 | EP1567005B1 Fungicides |
| 02/20/2008 | CN100369889C Process for synthesizing salicylamide |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/20/2008 | CN100369887C Inhibitors of oleamide hydrolase |
| 02/19/2008 | US7332629 Amide derivatives of the compound anacardic acid from Cashew Nut Shell Oil; to treat cancer, AIDS, HIV infection, and asthma |
| 02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/14/2008 | WO2006024627A9 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/14/2008 | US20080038213 1,3-Bis-[3-(4-methoxyphenyl)-2-propenoyloxy]-2-oxopropane; novel alpha-hydroxyketone derivatives as light-protection filters for cosmetic or drug products; used in cosmetic protective coatings; solar radiation; sunscreen agents; aging resistance; wrinkle resistance; food additives; dermatology |
| 02/13/2008 | EP1886990A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive neurodegenerative or neuronal diseases or disorders |
| 02/13/2008 | EP1517883B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/13/2008 | CN101121692A Synthesis method for alpha-carbonylamide compound |
| 02/13/2008 | CN101121675A Synthetic technique for tamibarotene |
| 02/13/2008 | CN100368386C Process for synthesizing (+/-)p-fluoro-2(2-methyl-propionyl)-4-oxy-N,3-diphenyl-phenylbutylamide |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329767 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 02/07/2008 | WO2008015241A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/07/2008 | WO2008015081A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 02/07/2008 | US20080033204 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 02/07/2008 | US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 02/07/2008 | CA2658797A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 02/07/2008 | CA2658552A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/06/2008 | EP1884510A1 N-substituted phenylacetamide derivative and pharmaceutical composition comprising the same |
| 02/06/2008 | EP1883634A2 Process for preparing simvastatin and intermediates thereof |
| 02/06/2008 | CN101119951A Modulator |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326803 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines |
| 02/05/2008 | US7326802 Dehydrogenation of propane forming propylene; vapor phase oxidation using mixed oxide catalyst |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | CA2216153C Dihalogenated ferrocenes and processes for the preparation thereof |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027115 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 01/31/2008 | CA2656166A1 Processes for the synthesis of o-desmethylvenlafaxine |
| 01/31/2008 | CA2656161A1 Process for the synthesis of o-desmethylvenlafaxine |
| 01/30/2008 | EP1881950A1 New compounds i |
| 01/30/2008 | CN101115710A Diamine calcium channel blockers |
| 01/29/2008 | US7323594 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/29/2008 | US7323496 Compounds for treatment of inflammation, diabetes and related disorders |
| 01/24/2008 | WO2008010765A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| 01/24/2008 | WO2008009138A1 Chlorogenic acid derivatives and their use as anti-fungal agents |
| 01/24/2008 | US20080021196 Inhibitors of memapsin 2 and use thereof |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021095 Small Molecule Antagonists of Xiap Family Proteins |
| 01/24/2008 | CA2657639A1 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity |
| 01/23/2008 | EP1879863A1 Amide resorcinol compounds |
| 01/23/2008 | CN101111472A Tetralin and indane derivatives and uses thereof |
| 01/22/2008 | US7321065 E.g., N-methyl-O-benzyl-tyramine, 3,5,3',5'-tetraiodothyroethanolamine; antagonist of a G protein coupled receptor and a trace amine receptor; antidepressants; nervous system disorders; antidiabetic agents; antiarrhymia disorders; glandular disorders of the thyroid; congestive heart failure; analgesics |
| 01/22/2008 | US7321056 Selective peroxisome proliferator activated receptor modulators |
| 01/22/2008 | CA2495967C New synthesis process and new crystalline form for agomelatine, and pharmaceutical compositions containing it |
| 01/22/2008 | CA2272598C A process for the preparation of 4-(des-dimethylamino)-tetracyclines |
| 01/17/2008 | WO2008007171A1 Positively charged water-soluble prodrugs of aspirin |
| 01/17/2008 | WO2006117602A3 Use of amide derivatives as taste-modifying agents, flavouring compositions and products containing them |
| 01/17/2008 | US20080015248 synthetic tea derived flavonoids, used for the of treatment of cancers; anticarcinogenic agents; enzyme inhibitors |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/16/2008 | EP1877365A1 Acetylene derivatives |
| 01/16/2008 | EP1085848B1 Inhibitors of transcription factor nf-kappa b |
| 01/16/2008 | CN101107219A Compounds for treating urinary incontinence |
| 01/16/2008 | CN101107217A Processes for the preparation of aminoethoxybenzyl alcohols |
| 01/16/2008 | CN101106968A 2 -C-substituted propane-1, 3 -dicarbonyl compounds and their use in neutralising malodour |
| 01/15/2008 | US7319160 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 01/10/2008 | WO2008003141A1 Therapeutic compounds |
| 01/10/2008 | US20080008764 Carbon-substituted diketopiperazine delivery systems |
| 01/10/2008 | DE102006059317A1 Verfahren zur Herstellung von β-Amino-α-hydroxy-carbonsäureamiden Process for the preparation of β-amino-α-hydroxy-carboxylic acid amides |
| 01/10/2008 | CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1203047B1 Electrically conductive polymers capable of being covalently grafted on by light, method for obtaining same and uses as supports in probes for specific identification in electronic biosensors |
| 01/09/2008 | CN100360512C Biphenylmethyl-thiazolidinediones and analogues and their use as PPAR-gamma activators |
| 01/08/2008 | US7317123 Process for preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation |
| 01/03/2008 | WO2008002576A2 Prolyl hydroxylase inhibitors and methods of use |
| 01/03/2008 | WO2008000438A1 Insecticidal compounds |
| 01/03/2008 | WO2008000410A1 Cxcr2 inhibitors |
| 01/03/2008 | WO2008000409A1 New cxcr2 inhibitors |
| 01/03/2008 | WO2008000408A1 Cxcr2 antagonists |
| 01/03/2008 | WO2008000407A1 Inhibitors of cxcr2 |
| 01/03/2008 | US20080004350 2-Fluoro-N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide, its enantiomers, and addition salts; melatoninergic disorders, circadian rhythm disorders, antidepressants, seasonal affective disorders, sleep disorders, jetlag |
| 01/03/2008 | US20080004348 Naphthalene compounds |
| 01/03/2008 | US20080004321 Potentiators of Glutamate Receptors |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/03/2008 | CA2656150A1 New cxcr2 inhibitors |
| 01/02/2008 | EP1871752A1 Amidopropoxyphenyl orexin receptor antagonists |
| 01/02/2008 | EP1871737A1 Method for producing acetoacetic acid arylamides |
| 01/02/2008 | EP1537069B1 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |